Rhythm Pharmaceuticals, Inc. Made Big Gain

Tue, Jul 12, 2022 at 08:30 PM
Rhythm Pharmaceuticals, Inc. Made Big Gain

Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) rocketted at $6.67, a gain of 42.2%. On Tue, Jul 12, 2022, RYTM:NASDAQ touched a New 2-Week High of $6.67. The stock appeared on our News Catalysts scanner on Tue, Jul 12, 2022 at 07:35 AM in the 'BIOTECH' category. From Tue, Jun 28, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days

About Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ)

Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.